Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by R. ALLERTON
The Use of Treosulfan and Gemcitabine in the Treatment of Platinum-Resistant Ovarian Cancer
Oncology Letters
Cancer Research
Oncology
Related publications
Targeted Treatment of Recurrent Platinum-Resistant Ovarian Cancer: Current and Emerging Therapies
Cancer Management and Research
Oncology
Oral Melphalan as a Treatment for Platinum-Resistant Ovarian Cancer
British Journal of Cancer
Cancer Research
Oncology
Is HIPEC Beneficial in Platinum Resistant Relapsed Ovarian Cancer?
Romanian Journal of Medical Practice
Prm212 - Patient Experience With Platinum-Resistant or Platinum-Refractory Ovarian Cancer
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
A Phase II Study of the Combination Chemotherapy of Bevacizumab and Gemcitabine in Women With Platinum-Resistant Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Journal of Ovarian Research
Gynecology
Oncology
Obstetrics
Establishment and Characterization of the Gemcitabine‑resistant Human Pancreatic Cancer Cell Line SW1990/gemcitabine
Oncology Letters
Cancer Research
Oncology
Bevacizumab in the Treatment of Ovarian Cancer
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
The Use of Monoclonal Antibodies for the Treatment of Epithelial Ovarian Cancer (Review)
International Journal of Oncology
Cancer Research
Oncology
Tumor Size and Overall Survival in Patients With Platinum-Resistant Ovarian Cancer Treated With Chemotherapy and Bevacizumab
Clinical Medicine Insights: Oncology
Oncology
